Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.
The Beauty Health Co.’s First-Mover Advantages Have Turned Goldman Sachs Analysts Bullish
First-mover advantages and projections of a rapidly growing medspa facial treatment market have made Goldman Sachs bullish on The Beauty Health Co. (NASDAQ: SKIN).
Goldman Sachs Initiates Coverage On Beauty Health with Buy Rating, Announces Price Target of $31
Goldman Sachs analyst Amit Hazan initiates coverage on Beauty Health (NASDAQ:SKIN) with a Buy rating and announces Price Target of $31.
The Beauty Health Company Joins Russell 3000 And 2000 Indexes Effective June 28
The Beauty Health Company ((", BeautyHealth", or the ", Company", , NASDAQ:SKIN), a global category-creator leading the charge with its flagship brand HydraFacial, today announced that it has joined
One In Five Russell 3000 Additions Went Public Via SPAC: What Investors Should Know
One of the biggest events for investors last week was the new additions to the Russell 3000 Index. The inclusion in the index means several ETFs have to add shares of the stocks as part of the rebalancing efforts.
Piper Sandler Initiates Coverage On Beauty Health with Overweight Rating, Announces Price Target of $24
Piper Sandler analyst Erinn Murphy initiates coverage on Beauty Health (NASDAQ:SKIN) with a Overweight rating and announces Price Target of $24.
Canaccord Genuity Initiates Coverage On Beauty Health with Buy Rating, Announces Price Target of $21
Canaccord Genuity analyst Kyle Rose initiates coverage on Beauty Health (NASDAQ:SKIN) with a Buy rating and announces Price Target of $21.
‘Fast Money’ Picks For June 14
On CNBC's "Fast Money Final Trades," James McDonald said he has a price target of $20 for Beauty Health Co (NASDAQ: SKIN).
Earnings Scheduled For May 13, 2021
Companies Reporting Before The Bell
• CASI Pharmaceuticals (NASDAQ:CASI) is estimated to report quarterly loss at $0.06 per share on revenue of $5.05 million.